(Total Views: 169)
Posted On: 04/17/2023 11:35:54 AM
Post# of 120823
$XBIT News Article - XBiotech Announces First Subject Enrollment in Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke https://marketwirenews.com/news-releases/xbio...49009.html
(0)
(0)
My Twitter: WhyteStocks